|
Volumn 157, Issue 4, 2007, Pages 803-804
|
Increasing the dose of cetirizine may lead to better control of chronic idiopathic urticaria: An open study of 21 patients [3]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHISTAMINIC AGENT;
CETIRIZINE;
FEXOFENADINE;
HISTAMINE H1 RECEPTOR ANTAGONIST;
LORATADINE;
PLACEBO;
CHRONIC DISEASE;
CLINICAL FEATURE;
DISEASE CONTROL;
DISEASE DURATION;
DOSE RESPONSE;
DROWSINESS;
DRUG DOSE INCREASE;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG INHIBITION;
FRIEDMAN TEST;
HUMAN;
IDIOPATHIC DISEASE;
LETTER;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANK SUM TEST;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
URTICARIA;
ADULT;
CETIRIZINE;
CHRONIC DISEASE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
HISTAMINE H1 ANTAGONISTS, NON-SEDATING;
HUMANS;
MIDDLE AGED;
SEVERITY OF ILLNESS INDEX;
URTICARIA;
|
EID: 34548548827
PISSN: 00070963
EISSN: 13652133
Source Type: Journal
DOI: 10.1111/j.1365-2133.2007.08060.x Document Type: Letter |
Times cited : (53)
|
References (8)
|